{
}
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UMB Bank n.a. now holds 971 shares of Agree Realty, valued at $73,000, after acquiring 299 additional shares last quarter. Arcadia Investment Management also entered a new stake worth $75,000. Institutional investors own 97.83% of the company, which operates 2,135 properties across 49 states. UBS Group raised its price target for Agree Realty from $77.00 to $79.00, indicating a potential upside of 3.76%. The stock has a "Moderate Buy" rating, with a consensus target price of $75.73, despite a recent earnings miss.
UBS AM significantly increased its stake in Essential Properties Realty Trust by 434% in Q3, now holding over 1 million shares valued at $37 million. Other institutional investors, including Glenmede Trust and Bank of Montreal, also raised their positions, contributing to 96.98% institutional ownership. Despite a "Moderate Buy" rating, analysts suggest better investment opportunities elsewhere, with UBS raising the price target to $40, indicating a potential upside.
Centersquare Investment Management LLC increased its stake in Four Corners Property Trust by 33.8%, now holding 19,426 shares valued at $456,000. The company, a real estate investment trust focused on restaurant and retail properties, has a "Moderate Buy" rating from analysts, with a consensus price target of $30.50. Recently, UBS Group initiated coverage with a "buy" rating and a $33.00 price target, indicating potential upside.
Natixis has increased its holdings in EPR Properties to 72,764 shares, valued at $3,089,000, after acquiring 47,534 shares last quarter. Price T Rowe Associates also boosted its stake by 48.3%, now owning 61,346 shares worth $2,605,000. Institutional investors hold 74.66% of the company's stock, which has a consensus "Hold" rating and a price target of $48.28.
UBS Group AG (NYSE:UBS) recently saw increased institutional investment, with Plato Investment Management acquiring 103,270 shares valued at approximately $3.19 million. Analysts maintain a "Moderate Buy" rating, with recent earnings surpassing expectations, reporting $0.43 EPS against a consensus of $0.28. The stock is currently trading at $31.61, down 1.4%, with a market cap of $101.36 billion.
As obesity rates soar, glucagon-like peptide-1 (GLP-1) receptor agonists are gaining traction for their significant weight-loss potential, with the market expected to exceed USD 160 billion by 2031. These medications not only aid in weight loss but also address various metabolic conditions, including type 2 diabetes and sleep apnea. However, challenges such as side effects and high costs may hinder long-term patient compliance, despite the growing demand for innovative obesity treatments.
UBS Group AG has restructured its investment banking leadership following the exit of several senior executives. Jon Levin will take on the role of global head of health care investment banking while retaining his position in consumer and retail, and Marc Warm has been appointed as the global head of leveraged and debt capital markets, reflecting the bank's focus on key sectors.
UBS Group AG has appointed new leaders in investment banking following recent senior departures, aiming to strengthen its health care and leveraged finance sectors. Jon Levin takes on the role of global head of health care, while Marc Warm becomes global head of leveraged and debt capital markets. Other notable appointments include Fergus Horrobin as chairman of global real estate and David Slade as vice chairman of global banking.
UBS Group AG has appointed Jon Levin as the global head of health care, in addition to his existing role as global head of consumer and retail, following the departure of David Kostel. This move is part of a broader strategy to strengthen leadership in investment banking, particularly in health care and leveraged finance.
As obesity rates soar globally, glucagon-like peptide-1 (GLP-1) receptor agonists are gaining traction for their significant weight-loss potential, with some users shedding up to 20% of their body weight. The market for these medications is projected to exceed USD 160 billion by 2031, addressing not only obesity but also related health issues like type 2 diabetes and cardiovascular risks. However, challenges such as side effects, high costs, and limited availability may hinder long-term patient compliance, despite the growing demand for innovative solutions in obesity treatment.
UBS Group AG
Companies
Royal Bank of Canada
Stifel, Nicolaus & Company Inc.
Truist Financial Corporation
Arcadia Investment Management Corp MI
Robert W. Baird & Co. Inc.
UBS Group AG
UMB Bank n.a.
Raymond James Financial, Inc.
USA
Show more
16:41 14.11.2024
Bank of Montreal Can
Glenmede Trust Co. NA
UBS Group AG
FMR LLC
Quantbot Technologies LP
USA
Peter M. Mavoides
Show more
16:37 14.11.2024
13:45 14.11.2024
Vanguard Group Inc.
Wells Fargo & Company
Royal Bank of Canada
Ontario Teachers Pension Plan Board
Natixis AM
StockNews.com
Price T Rowe Associates Inc.
UBS Group AG
JMP Securities LLC
Raymond James Financial, Inc.
USA
Tonya L. Mater
Show more
13:45 14.11.2024
13:32 14.11.2024
12:37 14.11.2024
05:57 14.11.2024
UBS Group AG
CHE
Jon Levin
David Kostel
David Slade
Indran Thana
Marc Warm
Fergus Horrobin
Michele Cousins
Alan Felder
Wolfgang Fuchs
Bethany Ropa
Show more
04:52 14.11.2024
04:52 14.11.2024
23:55 13.11.2024
Trending
Subcategory:
Cryptocurrency Markets
Cryptocurrency Trends
Stock Market Updates
Market Sentiment Analysis
Decentralized Finance (DeFi) Innovations
Central Bank Actions
Market Analysis and Predictions
Tokenomics and Crypto Economics
Inflation Rates & CPI Data
Hedge Funds & Private Equity
Cryptocurrency & Blockchain Regulations
Banking Regulations
Employment Reports
Cryptocurrency Regulations
Anti-Money Laundering (AML) Regulations
ESG & Sustainable Finance Regulations
Corporate Responsibility & ESG
Anti-Money Laundering (AML) & Know Your Customer
Blockchain Technology Adoption
Banking & Investment Regulations
Countries:
Companies:
Currencies:
People:
Apple Inc.
Ethereum USD
Solana USD
Ripple USD USD
Bitcoin USD
Coinbase Global, Inc.
Santiment Network Token USD
Bitwise Bitcoin ETF
NVIDIA Corporation
Ripples USD
JPMorgan Chase & Co.
BlackRock, Inc.
MicroStrategy Inc
Taiwan Semiconductor Manufacturing Co Ltd
Chainlink USD
Grayscale Bitcoin Trust ETF
Heritage Distilling Holding Company, Inc.
Robinhood Markets, Inc.
MARATHON DIGITAL
End Federal Reserve USD
United States Dollar
Armenian Dram
Euro
Vietnamese Đồng
British Pound Sterling
Canadian Dollar
New Zealand Dollar
Australian Dollar
Philippine Peso
Malagasy Ariary
Japanese Yen
Singapore Dollar
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.